spacer
spacer

PDBsum entry 3cyw

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Hydrolase PDB id
3cyw

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
99 a.a. *
Ligands
017
GOL
Metals
_CL ×5
Waters ×189
* Residue conservation analysis
PDB id:
3cyw
Name: Hydrolase
Title: Effect of flap mutations on structure of HIV-1 protease and inhibition by saquinavir and darunavir
Structure: HIV-1 protease. Chain: a, b. Synonym: retropepsin, pr. Engineered: yes. Mutation: yes
Source: Human immunodeficiency virus type 1. Gene: gag-pol. Expressed in: escherichia coli.
Resolution:
1.40Å     R-factor:   0.169     R-free:   0.234
Authors: F.Liu,I.T.Weber
Key ref:
F.Liu et al. (2008). Effect of flap mutations on structure of HIV-1 protease and inhibition by saquinavir and darunavir. J Mol Biol, 381, 102-115. PubMed id: 18597780 DOI: 10.1016/j.jmb.2008.05.062
Date:
27-Apr-08     Release date:   27-May-08    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
P04587  (POL_HV1B5) -  Gag-Pol polyprotein from Human immunodeficiency virus type 1 group M subtype B (isolate BH5)
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1447 a.a.
99 a.a.*
Key:    Secondary structure  CATH domain
* PDB and UniProt seqs differ at 6 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class 1: E.C.2.7.7.-  - ?????
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 2: E.C.2.7.7.49  - RNA-directed Dna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
DNA(n)
+ 2'-deoxyribonucleoside 5'-triphosphate
= DNA(n+1)
+ diphosphate
   Enzyme class 3: E.C.2.7.7.7  - DNA-directed Dna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
DNA(n)
+ 2'-deoxyribonucleoside 5'-triphosphate
= DNA(n+1)
+ diphosphate
   Enzyme class 4: E.C.3.1.-.-
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 5: E.C.3.1.13.2  - exoribonuclease H.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Exonucleolytic cleavage to 5'-phosphomonoester oligonucleotides in both 5'- to 3'- and 3'- to 5'-directions.
   Enzyme class 6: E.C.3.1.26.13  - retroviral ribonuclease H.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 7: E.C.3.4.23.16  - HIV-1 retropepsin.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Specific for a P1 residue that is hydrophobic, and P1' variable, but often Pro.
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1016/j.jmb.2008.05.062 J Mol Biol 381:102-115 (2008)
PubMed id: 18597780  
 
 
Effect of flap mutations on structure of HIV-1 protease and inhibition by saquinavir and darunavir.
F.Liu, A.Y.Kovalevsky, Y.Tie, A.K.Ghosh, R.W.Harrison, I.T.Weber.
 
  ABSTRACT  
 
HIV-1 (human immunodeficiency virus type 1) protease (PR) and its mutants are important antiviral drug targets. The PR flap region is critical for binding substrates or inhibitors and catalytic activity. Hence, mutations of flap residues frequently contribute to reduced susceptibility to PR inhibitors in drug-resistant HIV. Structural and kinetic analyses were used to investigate the role of flap residues Gly48, Ile50, and Ile54 in the development of drug resistance. The crystal structures of flap mutants PR(I50V) (PR with I50V mutation), PR(I54V) (PR with I54V mutation), and PR(I54M) (PR with I54M mutation) complexed with saquinavir (SQV) as well as PR(G48V) (PR with G48V mutation), PR(I54V), and PR(I54M) complexed with darunavir (DRV) were determined at resolutions of 1.05-1.40 A. The PR mutants showed changes in flap conformation, interactions with adjacent residues, inhibitor binding, and the conformation of the 80s loop relative to the wild-type PR. The PR contacts with DRV were closer in PR(G48V)-DRV than in the wild-type PR-DRV, whereas they were longer in PR(I54M)-DRV. The relative inhibition of PR(I54V) and that of PR(I54M) were similar for SQV and DRV. PR(G48V) was about twofold less susceptible to SQV than to DRV, whereas the opposite was observed for PR(I50V). The observed inhibition was in agreement with the association of G48V and I50V with clinical resistance to SQV and DRV, respectively. This analysis of structural and kinetic effects of the mutants will assist in the development of more effective inhibitors for drug-resistant HIV.
 
  Selected figure(s)  
 
Figure 3.
Fig. 3. F[o] − F[c] omit maps of SQV (upper panel) and DRV (lower panel) contoured at 3.3 σ. SQV is colored by atom type from complex PR[I54V]–SQV. DRV is from complex PR[I54V]–DRV, showing alternate conformations of 60%/40% occupancy. The major conformation is colored by atom type, whereas the minor conformation is shown in pink.
Figure 5.
Fig. 5. PR[I54M] interactions with inhibitors. (a) Major orientation of SQV. (b) Major orientation of DRV. Hydrogen bonds are indicated in red; CH–π interactions, in blue; and C–H…O interactions, in purple. Interatomic distances are shown in angstrom. Note that the water-mediated interaction of the NH2 of DRV with the Asp30 side chain is replaced by a direct hydrogen bond in the wild-type PR and the other mutant structures.
 
  The above figures are reprinted by permission from Elsevier: J Mol Biol (2008, 381, 102-115) copyright 2008.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21376058 M.K.Singh, K.Streu, A.J.McCrone, and B.N.Dominy (2011).
The evolution of catalytic function in the HIV-1 protease.
  J Mol Biol, 408, 792-805.  
20695887 C.H.Shen, Y.F.Wang, A.Y.Kovalevsky, R.W.Harrison, and I.T.Weber (2010).
Amprenavir complexes with HIV-1 protease and its drug-resistant mutants altering hydrophobic clusters.
  FEBS J, 277, 3699-3714.
PDB codes: 3nu3 3nu4 3nu5 3nu6 3nu9 3nuj 3nuo
20737578 J.M.Sayer, J.Agniswamy, I.T.Weber, and J.M.Louis (2010).
Autocatalytic maturation, physical/chemical properties, and crystal structure of group N HIV-1 protease: relevance to drug resistance.
  Protein Sci, 19, 2055-2072.
PDB code: 3mws
20195662 P.Dirauf, H.Meiselbach, and H.Sticht (2010).
Effects of the V82A and I54V mutations on the dynamics and ligand binding properties of HIV-1 protease.
  J Mol Model, 16, 1577-1583.  
19899162 R.Ishima, Q.Gong, Y.Tie, I.T.Weber, and J.M.Louis (2010).
Highly conserved glycine 86 and arginine 87 residues contribute differently to the structure and activity of the mature HIV-1 protease.
  Proteins, 78, 1015-1025.
PDB codes: 3jvw 3jvy 3jw2
  20228897 S.Qin, D.D.Minh, J.A.McCammon, and H.X.Zhou (2010).
Method to Predict Crowding Effects by Postprocessing Molecular Dynamics Trajectories: Application to the Flap Dynamics of HIV-1 Protease.
  J Phys Chem Lett, 1, 107-110.  
19535439 K.G.Sasková, M.Kozísek, P.Rezácová, J.Brynda, T.Yashina, R.M.Kagan, and J.Konvalinka (2009).
Molecular characterization of clinical isolates of human immunodeficiency virus resistant to the protease inhibitor darunavir.
  J Virol, 83, 8810-8818.
PDB codes: 3ggt 3ggu 3u7s
19254207 P.M.Colman (2009).
New antivirals and drug resistance.
  Annu Rev Biochem, 78, 95.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer